$HLGN
Heliogen Inc Stock $hlgn

$hlgn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000184029224000041 Filed on August 06, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$1.050M	$2.261M
YoY Change	-53.81%	62.2%
Cost Of Revenue	$1.110M	$3.929M
YoY Change	-40.29%	158.15%
Gross Profit	-$60.00K	-$1.668M
YoY Change	-114.49%	1203.13%
Gross Profit Margin	-5.71%	-73.77%
Selling, General & Admin	$7.854M	$9.505M
YoY Change	-47.63%	-46.15%
% of Gross Profit
Research & Development	$4.509M	$4.751M
YoY Change	-12.65%	-3.94%
% of Gross Profit
Depreciation & Amortization	$100.0K	$300.0K
YoY Change	-80.0%	-50.0%
% of Gross Profit
Operating Expenses	$12.57M	$18.38M
YoY Change	-37.67%	-18.65%
Operating Profit	-$12.63M	-$20.05M
YoY Change	-36.06%	-11.77%
Interest Expense	$535.0K	$675.0K
YoY Change	59.7%	150.0%
% of Operating Profit
Other Income/Expense, Net	$223.0K	$52.00K
YoY Change	-70.93%	-93.71%
Pretax Income	-$11.81M	-$19.28M
YoY Change	-36.38%	-11.07%
Income Tax	$1.000K	$2.000K
% Of Pretax Income
Net Earnings	-$11.82M	-$19.28M
YoY Change	-36.38%	-11.07%
Net Earnings / Revenue	-1125.24%	-852.81%
Basic Earnings Per Share	-$1.94	-$3.19
Diluted Earnings Per Share	-$1.94	-$3.19
COMMON SHARES
Basic Shares Outstanding	6.006M shares	5.970M shares
Diluted Shares Outstanding	6.086M shares	6.045M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$51.84M
YoY Change		-51.91%
Cash & Equivalents	$44.63M	$51.84M
Short-Term Investments		$0.00
Other Short-Term Assets		$2.981M
YoY Change		-34.02%
Inventory	$0.00	$0.00
Prepaid Expenses
Receivables		$4.028M
Other Receivables		$0.00
Total Short-Term Assets	$48.76M	$58.85M
YoY Change	-54.12%	-51.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$627.0K	$1.243M
YoY Change	-89.99%	-80.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.439M	$1.508M
YoY Change	-69.79%	-69.88%
Total Long-Term Assets	$9.232M	$10.44M
YoY Change	-68.82%	-66.83%
TOTAL ASSETS
Total Short-Term Assets	$48.76M	$58.85M
Total Long-Term Assets	$9.232M	$10.44M
Total Assets	$57.99M	$69.29M
YoY Change	-57.33%	-54.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.073M	$1.403M
YoY Change	-40.22%	66.04%
Accrued Expenses	$9.795M	$9.015M
YoY Change	3.76%	-7.86%
Deferred Revenue	$19.82M	$19.26M
YoY Change	50.48%	57.25%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$105.0M	$104.4M
YoY Change	105.58%	107.32%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities	$96.00K	$149.0K
YoY Change	-94.39%	-91.09%
Total Long-Term Liabilities	$96.00K	$149.0K
YoY Change	-94.39%	-91.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$105.0M	$104.4M
Total Long-Term Liabilities	$96.00K	$149.0K
Total Liabilities	$109.6M	$109.8M
YoY Change	66.54%	67.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$484.5M	-$472.7M
YoY Change	34.82%	38.7%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	-95.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$51.59M	-$40.48M
YoY Change
Total Liabilities & Shareholders Equity	$57.99M	$69.29M
YoY Change	-57.33%	-54.98%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$11.82M	-$19.28M
YoY Change	-36.38%	-11.07%
Depreciation, Depletion And Amortization	$100.0K	$300.0K
YoY Change	-80.0%	-50.0%
Cash From Operating Activities		-$9.285M
YoY Change		-34.73%
INVESTING ACTIVITIES
Capital Expenditures		$74.00K
YoY Change		-77.37%
Acquisitions
YoY Change
Other Investing Activities		$2.961M
YoY Change		-82.82%
Cash From Investing Activities		$2.887M
YoY Change		-82.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		2.000K
YoY Change		-99.81%
NET CHANGE
Cash From Operating Activities		-9.285M
Cash From Investing Activities		2.887M
Cash From Financing Activities		2.000K
Net Change In Cash		-6.396M
YoY Change		-270.33%
FREE CASH FLOW
Cash From Operating Activities		-$9.285M
Capital Expenditures		$74.00K
Free Cash Flow		-$9.359M
YoY Change		-35.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-40479000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44998000	usd
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0286
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0286
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0286
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y6M
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5989932	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5989932	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5946315	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5946315	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.19
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.19
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.79
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.68
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6045324	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6045324	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6033158	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6033158	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5676134	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5676134	shares
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	198000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-61000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	137000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32090000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21921000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-19282000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	681000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	13000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	106028000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-21683000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2816000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	168000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	927000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	88320000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8015000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-34507000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1967000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	13000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	28000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-40479000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125324000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	137000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-6383000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	168000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1162000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	88320000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-34507000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	795000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1193000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3354000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1008000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1729000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1967000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	-6383000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-252000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1237000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000	usd
	hlg	Non Cash Lease Expense NonCashLeaseExpense	936000	usd
	hlg	Non Cash Lease Expense NonCashLeaseExpense	828000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	159000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1340000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-628000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3331000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-227000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1413000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1247000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1213000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	258000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2718000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2377000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2046000	usd
	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	-577000	usd
	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	-934000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-638000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1521000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23598000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38357000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	224000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	854000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	461000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	81488000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12500000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	116500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12737000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	34158000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1155000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	13000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	168000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1323000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10876000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2876000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64215000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47874000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53339000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44998000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51839000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43498000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1000000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53339000	usd
	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	94000	usd
	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	139000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1000	usd
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	51800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-34500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23600000	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	4200000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and the accompanying notes. Despite our intention to establish accurate estimates and reasonable assumptions, actual results could differ materially from such estimates and assumptions.</span></div>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1740000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1778000	usd
	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	2049000	usd
	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1553000	usd
	us-gaap	Revenues Revenues	3789000	usd
	us-gaap	Revenues Revenues	3331000	usd
	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	0	usd
CY2024Q2	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	0	usd
CY2023Q2	hlg	Loss On Contracts Amortization LossOnContractsAmortization	900000	usd
	hlg	Loss On Contracts Amortization LossOnContractsAmortization	1300000	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	37200000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.42
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	966000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	954000	usd
CY2024Q2	us-gaap	Grants Receivable Current GrantsReceivableCurrent	3000000	usd
CY2023Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	3623000	usd
CY2024Q2	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	262000	usd
CY2023Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	309000	usd
CY2024Q2	hlg	Receivables Gross Current ReceivablesGrossCurrent	4228000	usd
CY2023Q4	hlg	Receivables Gross Current ReceivablesGrossCurrent	4886000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	207000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	4028000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4679000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	17008000	usd
	hlg	Contract With Customer Liability Increase For Deferred Revenue Additions ContractWithCustomerLiabilityIncreaseForDeferredRevenueAdditions	3336000	usd
	hlg	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	975000	usd
	hlg	Contract With Customer Liability Recognition Of Consideration Payable Excluding Opening Balance ContractWithCustomerLiabilityRecognitionOfConsiderationPayableExcludingOpeningBalance	94000	usd
	hlg	Contract With Customer Liability Other Excluding Opening Balance ContractWithCustomerLiabilityOtherExcludingOpeningBalance	-16000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19259000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1000000.0	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1411000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1870000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2709000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2424000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	53000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4120000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2391000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1956000	usd
CY2024Q2	us-gaap	Inventory Write Down InventoryWriteDown	1700000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1700000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5089000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10368000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3846000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4791000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1243000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5577000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	300000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	600000	usd
	us-gaap	Depreciation Depreciation	700000	usd
	us-gaap	Depreciation Depreciation	1200000	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	500000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	21000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1114000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1084000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	893000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1913000	usd
CY2024Q2	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	4285000	usd
CY2023Q4	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	3658000	usd
CY2024Q2	hlg	Inventory In Transit InventoryInTransit	0	usd
CY2023Q4	hlg	Inventory In Transit InventoryInTransit	29000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2303000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1792000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	420000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	431000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9015000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8907000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q2	hlg	Increase Decrease In Right Of Use Asset And Operating Lease Liabilities Due To Lease Remeasurement IncreaseDecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseRemeasurement	6400000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6688000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13909000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2303000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1792000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5177000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12878000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	697000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	688000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1403000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1352000	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	41000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	33000	usd
	us-gaap	Sublease Income SubleaseIncome	82000	usd
	us-gaap	Sublease Income SubleaseIncome	69000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	656000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	655000	usd
	us-gaap	Lease Cost LeaseCost	1321000	usd
	us-gaap	Lease Cost LeaseCost	1283000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.074
	us-gaap	Operating Lease Payments OperatingLeasePayments	1370000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1327000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	132000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	187000	usd
	hlg	Increase Decrease In Right Of Use Asset And Operating Lease Liabilities Due To Lease Remeasurement IncreaseDecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseRemeasurement	6417000	usd
	hlg	Increase Decrease In Right Of Use Asset And Operating Lease Liabilities Due To Lease Remeasurement IncreaseDecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseRemeasurement	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1431000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2854000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2372000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	967000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	539000	usd
CY2024Q2	hlg	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	549000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8712000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1232000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	7480000	usd
CY2023Q2	hlg	Share Purchase Right Plan Number Of Declared Dividend In Shares SharePurchaseRightPlanNumberOfDeclaredDividendInShares	1	shares
CY2023Q2	hlg	Share Purchase Right Plan Beneficial Ownership Acquired Percentage SharePurchaseRightPlanBeneficialOwnershipAcquiredPercentage	0.125
CY2023Q2	hlg	Share Purchase Right Plan Investors Beneficial Ownership Acquired Percentage SharePurchaseRightPlanInvestorsBeneficialOwnershipAcquiredPercentage	0.20
CY2024Q2	hlg	Share Purchase Right Plan Expiration Date Extension Period SharePurchaseRightPlanExpirationDateExtensionPeriod	P1Y
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-19282000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-21683000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-34507000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5976020	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5664853	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5964346	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5613243	shares
CY2024Q2	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	69304	shares
CY2023Q2	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	63408	shares
	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	68812	shares
	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	62891	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6045324	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5728261	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6033158	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5676134	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6045324	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5728261	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6033158	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5676134	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.19
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.19
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.79
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.68
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.35
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.35
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	681000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2816000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1967000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-6383000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	681000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2816000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1967000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-6383000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1008000	usd
CY2024Q2	us-gaap	Severance Costs1 SeveranceCosts1	613000	usd
CY2023Q2	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
	us-gaap	Severance Costs1 SeveranceCosts1	645000	usd
CY2023Q2	us-gaap	Business Exit Costs1 BusinessExitCosts1	0	usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1	161000	usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1	0	usd
CY2024Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	4128000	usd
CY2023Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	4160000	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	1480000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1000000.0	usd
	us-gaap	Severance Costs1 SeveranceCosts1	600000	usd
CY2024Q2	us-gaap	Severance Costs1 SeveranceCosts1	600000	usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1	200000	usd
CY2024Q2	us-gaap	Business Exit Costs1 BusinessExitCosts1	200000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	500000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd

Files In Submission

Name	View Source	Status
0001840292-24-000041-index-headers.html	Edgar Link	pending
0001840292-24-000041-index.html	Edgar Link	pending
0001840292-24-000041.txt	Edgar Link	pending
0001840292-24-000041-xbrl.zip	Edgar Link	pending
ex311-2024q210xq.htm	Edgar Link	pending
ex312-2024q210xq.htm	Edgar Link	pending
ex321-2024q210xq.htm	Edgar Link	pending
ex322-2024q210xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hlg-20240630.htm	Edgar Link	pending
hlg-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hlg-20240630_cal.xml	Edgar Link	unprocessable
hlg-20240630_def.xml	Edgar Link	unprocessable
hlg-20240630_lab.xml	Edgar Link	unprocessable
hlg-20240630_pre.xml	Edgar Link	unprocessable
hlg-20240630_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLGN
Heliogen Inc Stock $hlgn

2024 Q3 Form 10-Q Financial Statement

#000184029224000041 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN Heliogen Inc Stock $hlgn

2024 Q3 Form 10-Q Financial Statement

#000184029224000041 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN
Heliogen Inc Stock $hlgn